[go: up one dir, main page]

WO2008021788A3 - Polyamine compounds - Google Patents

Polyamine compounds Download PDF

Info

Publication number
WO2008021788A3
WO2008021788A3 PCT/US2007/075265 US2007075265W WO2008021788A3 WO 2008021788 A3 WO2008021788 A3 WO 2008021788A3 US 2007075265 W US2007075265 W US 2007075265W WO 2008021788 A3 WO2008021788 A3 WO 2008021788A3
Authority
WO
WIPO (PCT)
Prior art keywords
polyamine compounds
compounds
methods
formula
variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/075265
Other languages
French (fr)
Other versions
WO2008021788A2 (en
Inventor
Chi-Feng Yen
Chien-Huang Wu
Ying-Huey Huang
Chi-Hsin Richard King
Shu-Jen Chen
Hua-Chien Chen
Gholam Hossein Hakimelahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TaiGen Biotechnology Co Ltd
Original Assignee
TaiGen Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TaiGen Biotechnology Co Ltd filed Critical TaiGen Biotechnology Co Ltd
Publication of WO2008021788A2 publication Critical patent/WO2008021788A2/en
Publication of WO2008021788A3 publication Critical patent/WO2008021788A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention relates to methods for treating retinopathy and repairing tissue damage. The methods include administering to a subject in need thereof an effective amount of one or more compounds of the following formula (I): Each variable in this formula is defined in the specification.
PCT/US2007/075265 2006-08-08 2007-08-06 Polyamine compounds Ceased WO2008021788A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83616806P 2006-08-08 2006-08-08
US60/836,168 2006-08-08

Publications (2)

Publication Number Publication Date
WO2008021788A2 WO2008021788A2 (en) 2008-02-21
WO2008021788A3 true WO2008021788A3 (en) 2008-12-04

Family

ID=39082891

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/075265 Ceased WO2008021788A2 (en) 2006-08-08 2007-08-06 Polyamine compounds

Country Status (2)

Country Link
TW (1) TW200817365A (en)
WO (1) WO2008021788A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050043366A1 (en) * 2003-04-02 2005-02-24 Kak-Shan Shia Polyamine compounds for treating chemokine receptor mediated diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050043366A1 (en) * 2003-04-02 2005-02-24 Kak-Shan Shia Polyamine compounds for treating chemokine receptor mediated diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BUTLER J.M. ET AL.: "SDF-1 is Both Necessary and Sufficient to Promote Proliferative Retinopathy", JOURNAL OF CLINICAL INVESTIGATION, vol. 115, no. 1, January 2004 (2004-01-01), pages 86 - 93, XP009102858 *

Also Published As

Publication number Publication date
WO2008021788A2 (en) 2008-02-21
TW200817365A (en) 2008-04-16

Similar Documents

Publication Publication Date Title
WO2007136759A3 (en) Method for the treatment and prevention of ocular disorders
WO2008024439A3 (en) 4-aminoquinazoline derivatives and methods of use thereof
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
WO2010093849A3 (en) Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
WO2007133637A3 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2007095618A3 (en) Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
WO2007117971A3 (en) Ocular allergy treatments
EP2083862A4 (en) Compositions and methods for treating ocular diseases and conditions
WO2008029276A3 (en) Compositions and methods for the treatment of ophthalmic disease
WO2008022024A3 (en) Imidazole amines as inhibitors of beta-secretase
WO2008073463A3 (en) Methods and compositions for treating and monitoring treatment of il-13-associated disorders
WO2009079451A3 (en) Compositions and methods of promoting wound healing
WO2009117482A8 (en) Mtor inhibitor salt forms
IL186598A0 (en) Composition and method for the treatment or prevention of glaucoma and ocular hypertension
WO2007146983A3 (en) Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury
WO2008011487A3 (en) L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
WO2008011478A3 (en) Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
WO2009035634A3 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
WO2007120485A3 (en) Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
WO2008013986A3 (en) Compositions and methods for treating or preventing ophthalmic light toxicity
EP1984017A4 (en) Methods of treating or preventing tissue damage caused by increased blood flow
WO2007095250A3 (en) Compositions and methods for inhibiting optic nerve damage
WO2007074406A3 (en) Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
WO2008055022A3 (en) Carbamate compounds for use in treating depression

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07813799

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07813799

Country of ref document: EP

Kind code of ref document: A2